search
Back to results

Clinical Evaluation of Primary Sampling Scatter Correction for Chest Tomosynthesis

Primary Purpose

Pulmonary Nodule, Solitary, Pulmonary Nodule, Multiple

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Scatter corrected s-DCT
Sponsored by
UNC Lineberger Comprehensive Cancer Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Pulmonary Nodule, Solitary focused on measuring Chest, Lung, Tomography, Scatter

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with known lung lesion(s)
  • Patients having undergone a chest CT
  • Patients 18 years of age and older
  • Patients able to provide informed consent

Exclusion Criteria:

  • Patients who may not fit on a 35 x 35 detector (BMI > 35)
  • Planned procedures or therapies during study (in between SOC scans and study scan on s-DCT) (biopsy or removal of lung lesion)
  • Any woman who is pregnant, has reason to believe she is pregnant, or is lactating

Sites / Locations

  • University of North Carolina at Chapel Hill

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Scatter corrected s-DCT

Arm Description

The study scan, s-DCT and correction scan, will be performed within two weeks of the patient's clinical evaluations by chest CT and x-ray. The study scan may be done within 2 weeks prior or two weeks following standard of care imaging. There cannot be any intervening therapies or procedures (i.e. biopsy or excision of lesions) done in between the standard of care (SOC) imaging and the s-DCT. All patients will have a breath held s-DCT scan in an anterior-posterior direction.

Outcomes

Primary Outcome Measures

Reader Confidence in s-DCT Images Compared to Conventional CT (Units on a Scale)
Readers will rate their confidence in images from the experimental modality (sDCT with scatter correction) as compared to the conventional scan (chest CT with x-ray) on a 7 point Likert scale (-3 to 3) based on ability to identify lesion(s) present comparing each modality. A value of -3 is significantly less confident in the s-DCT representation 0 is the same confidence in modalities, and 3 is significantly more confident in the s-DCT representation compared to the conventional. Each individual will have a single value per reader. Two readers compared each scan. The overall reader preference between modalities was calculated by determining the mean value.

Secondary Outcome Measures

Sensitivity of s-DCT Images (Percentage of Positive Scans)
Sensitivity will be defined as the ability of s-DCT images to detect lesions positively identified on gold standard CT images.

Full Information

First Posted
August 27, 2019
Last Updated
August 5, 2022
Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
National Cancer Institute (NCI)
search

1. Study Identification

Unique Protocol Identification Number
NCT04076696
Brief Title
Clinical Evaluation of Primary Sampling Scatter Correction for Chest Tomosynthesis
Official Title
Clinical Evaluation of Primary Sampling Scatter Correction for Chest Tomosynthesis
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
August 26, 2020 (Actual)
Primary Completion Date
August 26, 2021 (Actual)
Study Completion Date
August 26, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
National Cancer Institute (NCI)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a study that will evaluate the utility of a scatter reduction technique in reducing dose and increasing the sensitivity of stationary digital chest tomosynthesis (s-DCT) in the detection of lung lesions.
Detailed Description
Digital tomosynthesis is an imaging modality that produces 3D sectional information using x-ray projections acquired over a limited scanning angle. Scatter is known to be the primary source of image degradation in x-ray based imaging. The investigators have developed an approach that measures scatter through a low dose (3% of the conventional scan) scatter measurement technique. Preliminary studies have shown that scatter reduction in DCT can significantly improve quality. The approach will characterize the reader confidence in lung nodule detection in a scatter corrected chest tomosynthesis imaging approach as compared to the conventional chest tomosynthesis. Fifty (50) patients who have undergone a clinical non-contrast CT with lung nodules will be asked to have an s-DCT (scan) within 4 weeks (+/- 2 week) of their clinical CT with no intervening procedures or therapies (i.e. biopsy of lung nodules). Investigators will then perform a reader study to evaluate the radiologist reader confidence in images generated from the scatter reduction technique versus more conventional chest tomosynthesis imaging.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulmonary Nodule, Solitary, Pulmonary Nodule, Multiple
Keywords
Chest, Lung, Tomography, Scatter

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
38 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Scatter corrected s-DCT
Arm Type
Experimental
Arm Description
The study scan, s-DCT and correction scan, will be performed within two weeks of the patient's clinical evaluations by chest CT and x-ray. The study scan may be done within 2 weeks prior or two weeks following standard of care imaging. There cannot be any intervening therapies or procedures (i.e. biopsy or excision of lesions) done in between the standard of care (SOC) imaging and the s-DCT. All patients will have a breath held s-DCT scan in an anterior-posterior direction.
Intervention Type
Device
Intervention Name(s)
Scatter corrected s-DCT
Intervention Description
All patients will have a breath held s-DCT scan in an anterior-posterior direction
Primary Outcome Measure Information:
Title
Reader Confidence in s-DCT Images Compared to Conventional CT (Units on a Scale)
Description
Readers will rate their confidence in images from the experimental modality (sDCT with scatter correction) as compared to the conventional scan (chest CT with x-ray) on a 7 point Likert scale (-3 to 3) based on ability to identify lesion(s) present comparing each modality. A value of -3 is significantly less confident in the s-DCT representation 0 is the same confidence in modalities, and 3 is significantly more confident in the s-DCT representation compared to the conventional. Each individual will have a single value per reader. Two readers compared each scan. The overall reader preference between modalities was calculated by determining the mean value.
Time Frame
Baseline
Secondary Outcome Measure Information:
Title
Sensitivity of s-DCT Images (Percentage of Positive Scans)
Description
Sensitivity will be defined as the ability of s-DCT images to detect lesions positively identified on gold standard CT images.
Time Frame
Baseline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with known lung lesion(s) Patients having undergone a chest CT Patients 18 years of age and older Patients able to provide informed consent Exclusion Criteria: Patients who may not fit on a 35 x 35 detector (BMI > 35) Planned procedures or therapies during study (in between SOC scans and study scan on s-DCT) (biopsy or removal of lung lesion) Any woman who is pregnant, has reason to believe she is pregnant, or is lactating
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ertan Pamuklar, MD
Organizational Affiliation
UNC Hospitals
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of North Carolina at Chapel Hill
City
Chapel Hill
State/Province
North Carolina
ZIP/Postal Code
27599
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.
IPD Sharing Time Frame
9 to 36 months following publication
IPD Sharing Access Criteria
The investigator who proposes to use the data has approval from an IRB, IEC, or REB, as applicable, and an executed data use/sharing agreement with UNC.

Learn more about this trial

Clinical Evaluation of Primary Sampling Scatter Correction for Chest Tomosynthesis

We'll reach out to this number within 24 hrs